Drug Topics Community Pharmacists' Report

July 31, 2012

Web Version  |   Unsubscribe  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

NCPA testifies at Rx drug gray market Senate hearing

At a hearing held last week about the prescription drug gray market, John Coster, PhD, RPh, senior vice president of government affairs, National Community Pharmacists Association, testified that a balanced approach was necessary to address the prescription drug shortage problem and to protect patient care. » More

Continuing Education

Cultural competency

Pharmacists need to gain insight into cultural competency to better serve the increasing racial and ethnic populations in the United States.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

FPA lawsuit: Restore access to community pharmacies

The Florida Pharmacy Association and others are suing to restore patient access to Medicaid pharmacy providers. » More

New FDA communication, label change for MS drug

FDA has announced a safety communication regarding the risk of seizures in patients with multiple sclerosis starting dalfampridine (Ampyra, Acorda Therapeutics). The safety communication stemmed from a review of post-marketing adverse event reports. » More

Omega-6 fatty acids may help prevent CHD

A new study has found that omega-6 poly-unsaturated fatty acids can help prevent coronary heart disease (CHD) and that dietary saturated fat increases the risk for CHD. » More

TAKE OUR SURVEY

Do you believe that the U.S. Supreme Court's ruling on the Affordable Care Act will bring about positive reform changes for patients and pharmacists?

a) Yes
b) No

Respond here and see what your colleagues think, too.

Want to see the results of our last survey which asked whether you supported the repeal of the ACA? Click here.

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out, too

OIG questions Part D billing practices

Pharmacy robot linked to contamination

Global drug spend projections report

Power to the people

Voices

DT Blog: State Boards of Pharmacy – watchdogs or lapdogs?

JP at Large: Pharmacy's crisis point

View from the Zoo: Stand up and make yourself heard

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group